U.S. Markets open in 36 mins.

Aratana Therapeutics, Inc. (PETX)

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Add to watchlist
5.47-0.05 (-0.91%)
At close: 4:00PM EDT
People also watch
OMEROMEDPTCTOCULKPTI
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue38,551678767
Cost of Revenue3,139365333
Gross Profit35,412313434
Operating Expenses
Research Development30,46224,96419,985
Selling General and Administrative27,34219,81917,938
Non Recurring8,04843,4822,229
Others3791,5441,891
Total Operating Expenses66,23189,80942,043
Operating Income or Loss-30,819-89,496-41,609
Income from Continuing Operations
Total Other Income/Expenses Net6405,3292,410
Earnings Before Interest and Taxes-30,179-84,167-39,199
Interest Expense3,3961,5851,060
Income Before Tax-33,575-85,752-40,259
Income Tax Expense--1,698-1,443
Minority Interest---
Net Income From Continuing Ops-33,575-84,054-38,816
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-33,575-84,054-38,816
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-33,575-84,054-38,816